These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3038364)

  • 1. Beneficial effects of a leukotriene antagonist on endotoxin-induced acute hemodynamic alterations.
    Etemadi AR; Tempel GE; Farah BA; Wise WC; Halushka PV; Cook JA
    Circ Shock; 1987; 22(1):55-63. PubMed ID: 3038364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effect of a selective leukotriene antagonist in endotoxemia in the rat.
    Cook JA; Wise WC; Halushka PV
    J Pharmacol Exp Ther; 1985 Nov; 235(2):470-4. PubMed ID: 2997435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of leukotriene receptor antagonists on vascular permeability during endotoxic shock.
    Cook JA; Li EJ; Spicer KM; Wise WC; Halushka PV
    Circ Shock; 1990 Nov; 32(3):209-18. PubMed ID: 2175680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primate myocardial and systemic hemodynamic responses to leukotriene D4: antagonism by LY171883.
    Hahn RA; MacDonald BR
    J Pharmacol Exp Ther; 1987 Jul; 242(1):62-9. PubMed ID: 3612538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance of essential fatty acid-deficient rats to endotoxin-induced increases in vascular permeability.
    Li EJ; Cook JA; Spicer KM; Wise WC; Rokach J; Halushka PV
    Circ Shock; 1990 Jun; 31(2):159-70. PubMed ID: 2188748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the leukotriene receptor antagonist LY-171883 on endotoxemia in awake sheep.
    Krausz MM; Dahan JB; Gross D
    Circ Shock; 1988 Dec; 26(4):431-41. PubMed ID: 2850874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukotriene D4 and hypoxia: differential effects on the pulmonary and systemic circulations in newborn piglets.
    Bradley LM; Feuerstein G; Goldstein RE; Czaja JF
    Eicosanoids; 1989; 2(1):15-20. PubMed ID: 2633795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of LY203647 on cardiovascular leukotriene D4 receptors and myocardial reperfusion injury.
    Hahn RA; MacDonald BR; Morgan E; Potts BD; Parli CJ; Rinkema LE; Whitesitt CA; Marshall WS
    J Pharmacol Exp Ther; 1992 Mar; 260(3):979-89. PubMed ID: 1312172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oleic acid-induced pulmonary injury in rats: potential role of sulfidopeptide leukotrienes.
    Ball HA; Cook JA; Spicer KM; Hsu CY; Halushka PV
    Circ Shock; 1988 Sep; 26(1):59-70. PubMed ID: 2847882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of dual cyclooxygense and leukotriene blockade with ibuprofen and LY203647 during canine endotoxic shock.
    Passmore JC; Jimenez AE
    Circ Shock; 1993 Jan; 39(1):21-8. PubMed ID: 8481974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the LTD4 receptor antagonist LY203647 on endotoxic shock sequelae in the rat.
    Li EJ; Cook JA; Ashton S; Wise WC; Halushka PV
    Eur J Pharmacol; 1991 Jun; 199(2):221-5. PubMed ID: 1954979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic and renal advantages of dual cyclooxygenase and leukotriene blockade during canine endotoxic shock.
    Young JS; Passmore JC
    Circ Shock; 1990 Nov; 32(3):243-55. PubMed ID: 2175681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of an orally active leukotriene D4/E4 antagonist, LY171883, on antigen-induced airway responses in allergic sheep.
    Abraham WM; Wanner A; Stevenson JS; Chapman GA
    Prostaglandins; 1986 Mar; 31(3):457-67. PubMed ID: 3754973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial effects of LY203647, a novel leukotriene C4/D4 antagonist, on pulmonary function and mesenteric perfusion in a porcine model of endotoxic shock and ARDS.
    Cohn SM; Kruithoff KL; Rothschild HR; Wang HL; Antonsson JB; Fink MP
    Circ Shock; 1991 Jan; 33(1):7-16. PubMed ID: 2009603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effects of a new LTD4 antagonist (LY-171883) in traumatic shock.
    Hock CE; Lefer AM
    Circ Shock; 1985; 17(4):263-72. PubMed ID: 3841503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-related antagonism of leukotriene D4-induced bronchoconstriction by p.o. administration of LY-171883 in nonasthmatic subjects.
    Phillips GD; Rafferty P; Robinson C; Holgate ST
    J Pharmacol Exp Ther; 1988 Aug; 246(2):732-8. PubMed ID: 3404455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concentration-dependent, stereoselective inhibition of the endotoxin-induced hemoconcentration in conscious rats with the peptidoleukotriene receptor antagonist SK & F 104353.
    Smith EF; Kinter LB; Jugus M; Eckardt RD; Newton JF
    Eicosanoids; 1989; 2(2):101-7. PubMed ID: 2560662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The improvement in endotoxin-induced redistribution of organ blood flow by inhibition of thromboxane and prostaglandin synthesis.
    Tempel GE; Cook JA; Wise WC; Halushka PV
    Adv Shock Res; 1982; 7():209-18. PubMed ID: 6753535
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of a platelet-activating factor antagonist, CV-3988, on different shock models in the rat.
    Toth PD; Mikulaschek AW
    Circ Shock; 1986; 20(3):193-203. PubMed ID: 3802423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endotoxemia in rats--influence of lipoxygenase blocker versus leukotriene receptor antagonist (BW755C vs LY171883).
    Bahrami S; Paul E; Redl H; Schlag G; Mihm F
    Prog Clin Biol Res; 1988; 272():283-92. PubMed ID: 2839854
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.